FI54315C - Foerfarande foer framstaellning av antiviral 2,6-diamino-9-(beta-d-arabinofuranosyl)purin - Google Patents

Foerfarande foer framstaellning av antiviral 2,6-diamino-9-(beta-d-arabinofuranosyl)purin

Info

Publication number
FI54315C
FI54315C FI3069/70A FI306970A FI54315C FI 54315 C FI54315 C FI 54315C FI 3069/70 A FI3069/70 A FI 3069/70A FI 306970 A FI306970 A FI 306970A FI 54315 C FI54315 C FI 54315C
Authority
FI
Finland
Prior art keywords
arabinofuranosyl
purin
diamino
antiviral
beta
Prior art date
Application number
FI3069/70A
Other languages
English (en)
Finnish (fi)
Other versions
FI54315B (fi
Inventor
Gertrude Belle Elion
Robert Albert Sterlitz
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI54315B publication Critical patent/FI54315B/fi
Application granted granted Critical
Publication of FI54315C publication Critical patent/FI54315C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI3069/70A 1969-11-17 1970-11-16 Foerfarande foer framstaellning av antiviral 2,6-diamino-9-(beta-d-arabinofuranosyl)purin FI54315C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
FI54315B FI54315B (fi) 1978-07-31
FI54315C true FI54315C (fi) 1978-11-10

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3069/70A FI54315C (fi) 1969-11-17 1970-11-16 Foerfarande foer framstaellning av antiviral 2,6-diamino-9-(beta-d-arabinofuranosyl)purin

Country Status (26)

Country Link
US (1) US3666856A (cs)
JP (1) JPS5429520B1 (cs)
AT (1) AT309696B (cs)
BE (1) BE759011A (cs)
BR (1) BR6915136D0 (cs)
CA (1) CA967564A (cs)
CH (2) CH555344A (cs)
CS (1) CS181701B2 (cs)
DE (1) DE2056327C2 (cs)
DK (1) DK128117B (cs)
ES (2) ES385590A1 (cs)
FI (1) FI54315C (cs)
FR (1) FR2073364B1 (cs)
GB (2) GB1338905A (cs)
HU (1) HU163812B (cs)
IE (1) IE34737B1 (cs)
IL (1) IL35658A (cs)
LU (1) LU62071A1 (cs)
MC (1) MC869A1 (cs)
NL (1) NL171589C (cs)
NO (1) NO128156B (cs)
PL (1) PL81167B1 (cs)
SE (1) SE385374B (cs)
YU (2) YU35033B (cs)
ZA (1) ZA707722B (cs)
ZM (1) ZM12970A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
DE2056327A1 (de) 1971-06-03
ES385590A1 (es) 1973-10-01
ZA707722B (en) 1972-06-28
AT309696B (de) 1973-08-27
IE34737L (en) 1971-05-17
FR2073364A1 (cs) 1971-10-01
MC869A1 (fr) 1971-09-28
GB1338906A (en) 1973-11-28
DK128117B (da) 1974-03-04
NO128156B (cs) 1973-10-08
LU62071A1 (cs) 1971-08-12
ZM12970A1 (en) 1972-07-21
FI54315B (fi) 1978-07-31
IE34737B1 (en) 1975-08-06
CH555833A (de) 1974-11-15
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
YU35033B (en) 1980-06-30
IL35658A0 (en) 1971-01-28
CH555344A (de) 1974-10-31
YU280670A (en) 1979-12-31
BE759011A (fr) 1971-05-17
NL171589C (nl) 1983-04-18
CS181701B2 (en) 1978-03-31
NL7016766A (cs) 1971-05-19
FR2073364B1 (cs) 1974-03-22
HU163812B (cs) 1973-10-27
JPS5429520B1 (cs) 1979-09-25
NL171589B (nl) 1982-11-16
US3666856A (en) 1972-05-30
BR6915136D0 (pt) 1973-04-19
SE385374B (sv) 1976-06-28
PL81167B1 (cs) 1975-08-30
IL35658A (en) 1974-10-22
DE2056327C2 (de) 1984-10-11
CA967564A (en) 1975-05-13
YU35034B (en) 1980-06-30
YU201978A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
FI54315B (fi) Foerfarande foer framstaellning av antiviral 2,6-diamino-9-(beta-d-arabinofuranosyl) purin
BE758910A (fr) Preparation de dimethyl-2, 2-propanediol-1, 3
AR199463A1 (es) Sintesis de nucleosidos de 1,2,4-triazol-3-sustituidos
FI48186C (fi) Parannettu tapa valmistaa 17alfa,21-dihydroksi-20-keto-steroidien 17-m onoestereitä
BE785575A (fr) Nucleosides de la purine
AR192316A1 (es) Un articulo de calzado
BR7019289D0 (pt) Conjunto de diferencial
BE756583A (fr) Derives de norbornyle
BE760483A (fr) Nouveaux derives de cyanophenyl-1,4-dyhydropyridine
FR2045022A5 (fr) Accelerometre
OA03416A (fr) Nouveau dérivé de l'adénine.
BE759013R (fr) Derives de la
BE754239R (fr) Nouvelles compositions acceleratrices de
BE749006A (fr) Preparation de polyalcenameres
BE752137R (fr) Production de
BE756360A (fr) Preparation continue de cyclohexanonoxime
AT301511B (de) Herstellung von 2-Äthylhexanal-(1)
BE760283A (fr) Preparation de mercapto-4-pyrazolo (3,4-d) pyrimidines
BE759839A (fr) Purification de monomeres
BE749790A (fr) Preparation de di-lithio(perfluoroalcoylethylsilyl) neocarboranes
BE746247A (fr) Nouveaux derives de la pyrimidine
AT297380B (de) Schmuckstück
BE760109A (fr) Nouveaux derives de la pyrimidine
BE752767A (fr) Nouvelles compositions de revetement
BE757955A (fr) Compositions antivirales